Comparison of risk stratification tools in predicting outcomes of patients with higher-risk myelodysplastic syndromes treated with azanucleosides

Overview of attention for article published in Leukemia, October 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news: 1 news outlet

twitter: 3 X users

Readers on

mendeley: 39 Mendeley

So far, Altmetric has seen 5 X posts from 3 X users, with an upper bound of 8,036 followers.

RT @garciamanero: Study comparing different risk factors in higher risk MDS https://t.co/1xBIE7nb2q https://t.co/MbOwIdHn3x

hnRPK important tumor suppressor gene in leukemogenesis #leuksm, https://t.co/1VOWRz49eu

Comparison of risk stratification tools in predicting outcomes of pts with higher-risk MDS treated with AZA. - NCBI https://t.co/1VOWRyMymW

Comparison of risk stratification tools in predicting outcomes of patients with higher-risk MDS treated with Aza - https://t.co/1VOWRz49eu

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.